Literature DB >> 6175830

Postjunctional selectivity of alpha-blockade with prazosin, trimazosin, and UK-33,274 in man.

W Singleton, C A Saxton, J Hernandez, B N Prichard.   

Abstract

The effects of 3 quinazoline alpha-adrenoreceptor antagonists, prazosin, trimazosin, and UK-33,274, on lying blood pressure (BP), BP response to 60 degrees tilt, pressor response to noradrenaline, phenylephrine, and exercise (isometric and dynamic) were measured in a double-blind study in 6 volunteers. There was no difference between the effects of prazosin 2 mg, trimazosin 200 mg, and UK-33,274 4 mg on lying and tilted BP or on BP response to exercise. All three drugs competitively antagonised the systolic and diastolic pressor effect of phenylephrine and the systolic pressor effect of noradrenaline. Prazosin and UK 33,274 completely suppressed the diastolic pressor effect of noradrenaline and produced an increase rather than a decrease in heart rate (HR). Trimazosin produced a parallel shift in noradrenaline dose response curves for diastolic pressure ahd HR. Prazosin and UK-33,274, but not trimazosin, therefore, produced effects unlike those previously described with alpha-blockers, e.g., phentolamine. The difference between antagonism of the systolic and diastolic effects suggests that the resistance component of the noradrenaline pressor effect, mediated principally via alpha 1-stimulation, is more effectively blocked than the cardiac component, which depends on venous return and alpha 2-mediated venoconstriction. Prazosin and UK-33,274 are clearly alpha 1-selective. Trimazosin is less selective.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175830     DOI: 10.1097/00005344-198200041-00029

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  13 in total

1.  Haemodynamic dose-response effects of UK-52,046 in ischaemic disease with or without impaired left ventricular function.

Authors:  B Silke; A V Zezulka; S P Verma; T C Tham; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

2.  Racial differences in drug responses--a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans.

Authors:  J Vincent; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

3.  A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients.

Authors:  P J Scott; J Hosie; M G Scott
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo.

Authors:  P Smyth; S Pringle; G Jackson; A R Lorimer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha 1-adrenoceptor responsiveness of trimazosin in man.

Authors:  J Vincent; H L Elliott; P A Meredith; D M Hughes; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.

Authors:  C A Hamilton; J L Reid; J Vincent
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

7.  Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonist.

Authors:  P W de Leeuw; J J Ligthart; A J Smout; W H Birkenhäger
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Chronic infusion of clonidine does not alleviate spontaneous morphine withdrawal symptoms in rats.

Authors:  J W van der Laan; C Jansen van't Land
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Dose-dependent alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic drug, abanoquil (UK-52,046), without reduction in blood pressure in man.

Authors:  T C Tham; S Guy; R G Shanks; D W Harron
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

10.  Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.

Authors:  P Lund-Johansen; P Omvik; H Haugland
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.